Global prevalence and major risk factors of diabetic retinopathy

scientific article

Global prevalence and major risk factors of diabetic retinopathy is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.2337/DC11-1909
P932PMC publication ID3322721
P698PubMed publication ID22301125
P5875ResearchGate publication ID221801974

P50authorTrevor J. OrchardQ30223717
Ecosse L LamoureuxQ75156305
Sheila K. WestQ85241581
Paul MitchellQ96121027
Hugh R. TaylorQ37393483
James M TielschQ40261966
Massimo PortaQ43273739
Ronald KleinQ44045637
Jakob GrauslundQ56761243
Steven M. HaffnerQ64431345
Richard F. HammanQ64454798
P2093author name stringJacqueline M Dekker
Barbara E K Klein
Jie Jin Wang
Jonathan Shaw
Tien Y Wong
Xinzhi Zhang
Liang Xu
M Kamran Ikram
Rohit Varma
Toke Bek
Sannapaneni Krishnaiah
Ningli Wang
Ryo Kawasaki
Takamasa Kayama
Tarun Sharma
Jonathan W Kowalski
Astrid Fletcher
Shih-Jen Chen
Sophie L Rogers
Miho Yasuda
Korapat Mayurasakorn
Mohan Rema
Joseph P O'Hare
Monique S Roy
Joanne W Y Yau
Meta-Analysis for Eye Disease (META-EYE) Study Group
P2860cites workThe role of genetics in susceptibility to diabetic retinopathyQ24651324
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupQ27861088
Global estimates of the prevalence of diabetes for 2010 and 2030Q29547218
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesQ29547541
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialQ29622926
Diabetic retinopathy in Victoria, Australia: the Visual Impairment ProjectQ31793083
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edemaQ70741925
3. Sampling variance of standardized mortality ratesQ72938359
Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factorsQ73356592
Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VERQ74086486
Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye StudyQ32098483
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.Q33305306
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialQ33966645
Prevalence of diabetic retinopathy in the United States, 2005-2008.Q34154127
The prevalence of and factors associated with diabetic retinopathy in the Australian populationQ34199750
Diabetic retinopathy in a multi-ethnic cohort in the United StatesQ36464921
Overview of epidemiologic studies of diabetic retinopathyQ36951796
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysisQ37437199
Prevalence of diabetes among men and women in ChinaQ39605920
The prevalence of diabetic retinopathy among adults in the United StatesQ40517905
Diabetic retinopathy in Mexican Americans and non-Hispanic whitesQ44037303
Prevalence of diabetic retinopathy in rural China: the Handan Eye StudyQ46148180
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye StudyQ46515278
Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I.Q46568353
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United StatesQ46749381
Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairmentQ46893482
Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population studyQ46930900
Is there an ethnic difference in the effect of risk factors for diabetic retinopathy?Q47274305
Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM.Q51053891
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study.Q53619110
The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitusQ67756835
Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathyQ67957877
Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes StudyQ69749970
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 yearsQ70330511
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more yearsQ70330516
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivativesQ6937225
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectdiabetic retinopathyQ631361
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)556-564
P577publication date2012-02-01
2012-03-01
P1433published inDiabetes CareQ5270111
P1476titleGlobal prevalence and major risk factors of diabetic retinopathy
P478volume35

Reverse relations

cites work (P2860)
Q508612521,25-Dihydroxyvitamin D3 Deficiency is Involved in the Pathogenesis of Diabetic Retinopathy in the Uygur Population of China.
Q94461905A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study)
Q38677861A Comprehensive Study of Retinal Vessel Classification Methods in Fundus Images
Q59796439A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury
Q42684832A Diabetic Retinopathy Screening Tool for Low-Income Adults in Mexico
Q37202995A Meta-Analysis of Association between Methylenetetrahydrofolate Reductase Gene (MTHFR) 677C/T Polymorphism and Diabetic Retinopathy
Q94453419A New Approach for Diabetic Macular Edema Treatment: review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes
Q58597926A Novel Vision-Enhancing Technology for Low-Vision Impairments
Q64900527A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography.
Q37731896A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study
Q89965756A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy
Q34985146A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia
Q37485876A bibliometric analysis of academic publication on diabetic retinopathy disease trends during 1980-2014: a global and medical view
Q54130366A clinical correlation of conjunctival microangiopathy with grades of retinopathy in type 2 diabetes mellitus.
Q100750415A cross-sectional study on diabetes epidemiology among people aged 40 years and above in Shenyang, China
Q55384382A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
Q47230436A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema
Q34510550A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.
Q35592903A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series
Q36872704A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
Q39089813A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
Q64101207A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Q57157493A review of the multifunctionality of angiopoietin-like 4 in eye disease
Q27008325A review of therapies for diabetic macular oedema and rationale for combination therapy
Q37405425A simple integrated primary health care based model for detection of diabetic retinopathy in resource-limited settings in Pakistani population
Q37444532A study on the association of diabetic dermopathy with nephropathy and retinopathy in patients with type 2 diabetes mellitus
Q58718911A super-resolution method-based pipeline for fundus fluorescein angiography imaging
Q38175406Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases
Q92738470Accumulation of advanced glycation end products potentiate human retinal capillary endothelial cells mediated diabetic retinopathy
Q33817379Accuracy and reliability of retinal photo grading for diabetic retinopathy: Remote graders from a developing country and standard retinal photo grader in Australia
Q92642592Accuracy of the smartphone-based nonmydriatic retinal camera in the detection of sight-threatening diabetic retinopathy
Q39141199Acircularity index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls measured by optical coherence tomography angiography
Q55447099Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
Q35962947Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review
Q41998002Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
Q92534563Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia
Q58557619Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review
Q38088818Advances in our understanding of diabetic retinopathy.
Q36766212Advances in retinal imaging for diabetic retinopathy and diabetic macular edema
Q60929999Advancing Health Disparities Research in Population Health
Q53704361Aflibercept in Diabetic Macular Oedema Previously Refractory to Standard Intravitreal Therapy: An Irish Retrospective Study.
Q27334828African Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans
Q35116153Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese
Q98945457Altered Intrinsic Brain Activities in Patients with Diabetic Retinopathy Using Amplitude of Low-frequency Fluctuation: A Resting-state fMRI Study
Q37542643An Automated Detection System for Microaneurysms That Is Effective across Different Racial Groups
Q41973311An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1.
Q49993165An overview of the clinical outcomes of the fluocinolone acetonide 190 µg intravitreal implant clinical evidence study in the United Kingdom (ICE-UK).
Q55021084Analysis of Changes in Retinal Thickness in Type 2 Diabetes without Diabetic Retinopathy.
Q57493143Analysis of Foveal Microvascular Abnormalities in Diabetic Retinopathy Using Optical Coherence Tomography Angiography with Projection Artifact Removal
Q89579353Analysis of association between common variants of uncoupling proteins genes and diabetic retinopathy in a Chinese population
Q89663550Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study
Q93172776Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats
Q34251889Angiotensin II-related hypertension and eye diseases
Q41504603Animal Models of Diabetic Retinopathy
Q36959934Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics
Q64083037Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema
Q91842594Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice
Q93384458Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema
Q24187587Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
Q54115470Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Q57456682Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
Q34558187Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Q47147918Anti-vascular endothelial growth factor indications in ocular disease
Q62089583Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy
Q56775677Application of higher-order spectra for automated grading of diabetic maculopathy
Q33773561Application of random forests methods to diabetic retinopathy classification analyses
Q53490476Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy.
Q51454835Aqueous humour concentrations of TGF-β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy.
Q61446484Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China
Q88007076Are light masks useful for early diabetic macular oedema?
Q38451253Are reactive oxygen species still the basis for diabetic complications?
Q92025402Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy
Q58553410Artificial intelligence and deep learning in ophthalmology
Q93134057Artificial intelligence for diabetic retinopathy screening: a review
Q104485906Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study
Q104478923Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study
Q92914581Artificial intelligence-based screening for diabetic retinopathy at community hospital
Q36629520Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy
Q48499144Assessment of Annual Diabetic Eye Examination Using Telemedicine Technology Among Underserved Patients in Primary Care Setting.
Q33702923Assessment of macular function using the SKILL Card in adults with type 2 diabetes mellitus
Q96684015Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis
Q37533412Assessment of the Relationship between Diabetic Retinopathy and Nailfold Capillaries in Type 2 Diabetics with a Noninvasive Method: Nailfold Videocapillaroscopy
Q92463409Associated risk factors in the early stage of diabetic retinopathy
Q47215013Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes
Q91898492Association between Hyperreflective Foci on Spectral-Domain Optical Coherence Tomography and Early Recurrence of Diabetic Macular Edema after Intravitreal Dexamethasone Implantation
Q49827267Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Q57045583Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review
Q42137930Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects
Q47111812Association between the number of natural teeth and diabetic retinopathy among type 2 diabetes mellitus: The Korea national health and nutrition examination survey
Q53267477Association of ARHGAP22 gene polymorphisms with the risk of type 2 diabetic retinopathy.
Q36363393Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis
Q91601723Association of FokI, TaqI, BsmI and ApaI polymorphisms with diabetic retinopathy: a pooled analysis of case-control studies
Q55102286Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients.
Q37504145Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)
Q90446393Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers
Q57219568Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey
Q41145559Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study
Q34419106Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes
Q36148134Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
Q35745320Association of retinopathy and intima media thickness of common carotid artery in type 2 diabetic patients
Q41874907Association of serum lipids with diabetic retinopathy in type 2 diabetes
Q64282639Association of the Serum Total Cholesterol to Triglyceride Ratio with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Community-Based Study
Q54961322Associations between sleep duration, sleep quality and diabetic retinopathy.
Q50098051Associations of Physical Activity and Sedentary Behaviour with Vision-Threatening Diabetic Retinopathy in Indonesian Population with Type 2 Diabetes Mellitus: Jogjakarta Eye Diabetic Study in the Community (JOGED.COM).
Q64122411Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study
Q55711848Astragaloside IV protects RGC-5 cells against oxidative stress.
Q92370282Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells
Q55416398Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography.
Q47137147Automated detection of photoreceptor disruption in mild diabetic retinopathy on volumetric optical coherence tomography.
Q50072679Automated segmentation of hyperreflective foci in spectral domain optical coherence tomography with diabetic retinopathy.
Q99551232Automatic detection of non-perfusion areas in diabetic macular edema from fundus fluorescein angiography for decision making using deep learning
Q36899665Automatic differentiation of color fundus images containing drusen or exudates using a contextual spatial pyramid approach
Q92969312Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in primary health care in security forces hospital Riyadh, Saudi Arabia
Q53695752Awareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia.
Q64281576Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia
Q39417384Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
Q92384173Barriers for Adherence to Diabetic Retinopathy Screening among Saudi Adults
Q54988945Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.
Q41995332Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy
Q54981625Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus.
Q89567602Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study
Q36092355Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
Q33583030Biomarkers in Diabetic Retinopathy
Q39223411Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.
Q42123271Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.
Q53413992Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.
Q37628516Body mass index and retinopathy in type 1 diabetic patients.
Q33765398Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review
Q37368103Body mass index: a risk factor for retinopathy in type 2 diabetic patients
Q64330052Bone Marrow CD133 Stem Cells Ameliorate Visual Dysfunction in Streptozotocin-induced Diabetic Mice with Early Diabetic Retinopathy
Q36988482Botanical compounds: effects on major eye diseases
Q38613091Brain functional networks: correlation analysis with clinical indexes in patients with diabetic retinopathy
Q60955477Burden of diabetic retinopathy in mainland China: Protocol for an updated systematic review and meta-analysis of prevalence and risk factors to identify prevention policies
Q36622467C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus
Q41459896CDKAL1 rs7756992 is associated with diabetic retinopathy in a Chinese population with type 2 diabetes.
Q50205839Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
Q38295438Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis
Q64066763Can the appropriateness of eye care be measured through cross-sectional retrospective patient record review in eye care practices in Australia? The iCareTrack feasibility study
Q35925938Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema
Q36705336Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy
Q104070102Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
Q92594584Central Macular Thickness in Diabetic Patients: A Sex-based Analysis
Q26998699Challenges in elucidating the genetics of diabetic retinopathy
Q91637896Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Q36010448Changes in retinal microvascular diameter in patients with diabetes
Q36156286Changes in the Macular Ganglion Cell Complex Thickness and Central Macular Thickness after Argon Laser Panretinal Photocoagulation
Q37310218Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population
Q37397066Changing Clinical Presentation, Current Knowledge-Attitude-Practice, and Current Vision Related Quality of Life in Self-Reported Type 2 Diabetes Patients with Retinopathy in Eastern India: The LVPEI Eye and Diabetes Study
Q35717962Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy
Q90397106Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia
Q90413555Choroidal Thickness and Urinary Albumin Excretion in Type 2 Diabetic Patients without Retinopathy
Q64986317Circular RNAs: Novel Promising Biomarkers in Ocular Diseases.
Q26744760Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Q90374530Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 3-year Pilot Study Evaluating Morpho-Functional Retinal Changes
Q38994731Clinical Components of Telemedicine Programs for Diabetic Retinopathy
Q37516050Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.
Q36222032Clinical Evaluation of Correlation Between Diabetic Retinopathy with Modifiable, Non-Modifiable and Other Independent Risk Factors in Tertiary Set-up in Central Rural India
Q36379507Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects
Q38608755Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes.
Q35996718Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
Q33933846Clinical features of diabetic patients referred by general physicians due to less ophthalmic examinations
Q36159029Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists
Q33899234Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography
Q34139793Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Q53614209Combination of Bevacizumab and NGF Reduces the Risk of Diabetic Retinopathy.
Q41528726Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
Q35195660Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats
Q89241658Commentary on "Community care for diabetic retinopathy and glaucoma in India: A panel discussion"
Q41144757Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.
Q90353204Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy
Q33444386Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography
Q36393864Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: the multicenter Brazilian Type 1 Diabetes Study
Q37607065Comparison of Cysts in Red and Green Images for Diabetic Macular Edema
Q55362259Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema.
Q35722473Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema
Q91842539Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
Q48316496Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
Q41025677Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
Q92073684Computer aided diabetic retinopathy detection based on ophthalmic photography: a systematic review and Meta-analysis
Q58094539Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
Q92112467Cone photoreceptor density in type I diabetic patients measured with an adaptive optics retinal camera
Q98613395Conjunctival Microangiopathy in Diabetes Mellitus Assessed with Optical Coherence Tomography Angiography
Q53766666Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism.
Q58710225Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial
Q41007892Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
Q64951612Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.
Q90004592Correlation of retinal vascular perfusion density with dark adaptation in diabetic retinopathy
Q64092412Correlations among Diabetic Microvascular Complications: A Systematic Review and Meta-analysis
Q92578847Correlations between visual acuity and macular microvasculature quantified with optical coherence tomography angiography in diabetic macular oedema
Q34267270Corticosteroid use for diabetic macular edema: old fad or new trend?
Q90220983Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review
Q36095304Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Q91563960Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema
Q60913080Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
Q41678993Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study
Q59447403Curcumin Modulates DNA Methyltransferase Functions in a Cellular Model of Diabetic Retinopathy
Q33447283Current and Next Generation Portable Screening Devices for Diabetic Retinopathy
Q34750020Current concepts in diabetic retinopathy
Q38010064Current epidemiology of diabetic retinopathy and diabetic macular edema
Q59797373Current management of diabetic tractional retinal detachments
Q55259517Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography.
Q55382668Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy.
Q92448282Deep and Densely Connected Networks for Classification of Diabetic Retinopathy
Q91869666Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study
Q90056412Deep learning-based single-shot prediction of differential effects of anti-VEGF treatment in patients with diabetic macular edema
Q38749195Delayed follow-up in patients with diabetic retinopathy in South India: Social factors and impact on disease progression
Q31155420Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials
Q100307184Density-based classification in diabetic retinopathy through thickness of retinal layers from optical coherence tomography
Q90635453Design, Development, and Evaluation of a Teleophthalmology System Using a Low-Cost Fundus Camera
Q94551036Design, implementation, and evaluation of a nurse-led intravitreal injection programme for retinal diseases in Singapore
Q92003034Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats
Q49199328Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Q97525481Detection of Diabetic Retinopathy Using Bichannel Convolutional Neural Network
Q91967115Determinants of diabetic retinopathy in Southwest Ethiopia: a facility-based case-control study
Q45942996Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
Q64257305Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
Q46249426Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome.
Q92696069Dexamethasone implant in the management of diabetic macular edema from clinician's perspective
Q50922705Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study.
Q35828114Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
Q26799423Dexamethasone intravitreal implant in the treatment of diabetic macular edema
Q47123458Diabetes and Diabetic Retinopathy: Knowledge, Attitude, Practice (KAP) among Diabetic Patients in A Tertiary Eye Care Centre
Q35017752Diabetes and retinal vascular dysfunction
Q93035199Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken
Q93014563Diabetes retinopathy and related health management in Asians versus whites using BRFSS 2005-2017 data
Q64980448Diabetic Macular Edema: Is Your Patient Going Blind?
Q94453474Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study
Q95641816Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema
Q37477129Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population
Q36556183Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic
Q28356500Diabetic Retinopathy Screening Using Telemedicine Tools: Pilot Study in Hungary
Q48207622Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance
Q28076765Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs
Q92130384Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network
Q92537532Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
Q34551730Diabetic Retinopathy: A Position Statement by the American Diabetes Association.
Q58579972Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies
Q37494858Diabetic Retinopathy: Battling the Global Epidemic
Q88657191Diabetic Retinopathy: Focus on Minority Populations
Q38865568Diabetic brain or retina? Visual psychophysical performance in diabetic patients in relation to GABA levels in occipital cortex
Q36766200Diabetic care initiatives to prevent blindness from diabetic retinopathy in India
Q38816237Diabetic choroidopathy: a review of the current literature
Q26830284Diabetic complications in obese type 2 diabetic rat models
Q43109414Diabetic complications: current challenges and opportunities.
Q59797366Diabetic macular edema: Evidence-based management
Q33713517Diabetic macular edema: new concepts in patho-physiology and treatment
Q36096676Diabetic macular oedema
Q47310979Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines
Q30234323Diabetic macular oedema: clinical risk factors and emerging genetic influences.
Q30101045Diabetic macular oedema: evidence-based treatment recommendations for Asian countries.
Q36018006Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
Q95578275Diabetic retinopathy
Q55446891Diabetic retinopathy among Brazilian Xavante Indians.
Q98464363Diabetic retinopathy among Omanis: Prevalence and clinical profile
Q92964630Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy
Q96172012Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Q88611041Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus
Q37346399Diabetic retinopathy and its risk factors at the university hospital in Jamaica.
Q42193031Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study
Q36555926Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia
Q89928675Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?
Q89928669Diabetic retinopathy screening and treatment in Myanmar: a pilot study
Q55241071Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data.
Q98947044Diabetic retinopathy screening in persons with mental illness: a literature review
Q39451009Diabetic retinopathy: Breaking the barrier
Q37703546Diabetic retinopathy: Knowledge, awareness and practices of physicians in primary-care centers in Riyadh, Saudi Arabia
Q38365800Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Q39445950Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Q38682902Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
Q49887766Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond.
Q35975239Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema
Q38199730Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Q39208422Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.
Q34498235Diabetic retinopathy: pathogenesis, clinical grading, management and future developments
Q53832992Diabetics Retinopathy Knowledge and Awareness Assessment among the Type 2 Diabetics.
Q38853204Diagnostic performance of retinal digital photography for diabetic retinopathy screening in primary care
Q47330811Diet and risk of diabetic retinopathy: a systematic review
Q36884076Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC).
Q40303756Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study.
Q92102799Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review
Q26470625Different lasers and techniques for proliferative diabetic retinopathy
Q52653937Different lasers and techniques for proliferative diabetic retinopathy.
Q55325329Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations.
Q64104671Digital image processing software for diagnosing diabetic retinopathy from fundus photograph
Q99212624Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective
Q90950418Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture
Q37321649Divergent Perceptions of Barriers to Diabetic Retinopathy Screening Among Patients and Care Providers, Los Angeles, California, 2014-2015.
Q92701923Do Genomic Factors Play a Role in Diabetic Retinopathy?
Q93013182Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective
Q35669943Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a "Protective" Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients?
Q40051233Does the 'slipping slipper sign' in patients with diabetes predict the presence of retinopathy and nephropathy?
Q28074223Does tight control of systemic factors help in the management of diabetic retinopathy?
Q48209586E2f1 mediates high glucose-induced neuronal death in cultured mouse retinal explants
Q91693232Early Detection of Microvascular Changes in Patients with Diabetes Mellitus without and with Diabetic Retinopathy: Comparison between Different Swept-Source OCT-A Instruments
Q42379751Early changes in retinal structure and BMP2 expression in the retina and crystalline lens of streptozotocin-induced diabetic pigs
Q94038538Effect of Glucose on Retinal Endothelial Cell Viability and VEGF Secretion
Q92642597Effect of health education and screening location on compliance with diabetic retinopathy screening in a rural population in Maharashtra
Q64059372Effect of ripasudil on diabetic macular edema
Q50220747Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.
Q90070733Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina
Q94474862Effect of vitamin B12 supplementation on retinal lesions in diabetic rats
Q93131685Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
Q58809070Effectiveness of peer support to increase uptake of retinal examination for diabetic retinopathy: study protocol for the DURE pragmatic cluster randomized clinical trial in Kirinyaga, Kenya
Q89002608Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema
Q55270087Effects of Diets with Different Proportions of Protein/Carbohydrate on Retinal Manifestations in db Mice.
Q90282553Effects of Hypertension, Diabetes, and Smoking on Age and Sex Prediction from Retinal Fundus Images
Q35557492Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis
Q85890421Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
Q41105960Effects of water drinking test on ocular blood flow waveform parameters: A laser speckle flowgraphy study
Q36331293Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema
Q36949135Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.
Q36088924Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
Q48213638Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol
Q94476057Efficacy of switching therapy to aflibercept for patients with persistent diabetic macular edema: a systematic review and meta-analysis
Q36021525Electronic Patient Records to Identify Patients in the United Kingdom with Diabetic Macular Oedema Suitable for ILUVIEN(®) (Fluocinolone Acetonide).
Q58748857Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes
Q38912512Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy.
Q38241679Emerging drugs for diabetic macular edema
Q92859254Emerging therapies in the management of macular edema: a review
Q40262807Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements
Q98577923Ensemble Deep Learning for Diabetic Retinopathy Detection Using Optical Coherence Tomography Angiography
Q27003941Epidemiological issues in diabetic retinopathy
Q28074027Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998-2015: a systematic review and meta-analysis
Q26775552Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Q36648831Epigenetic Mechanisms of the Aging Human Retina
Q37291255Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway
Q36842815Estimating the proportion of persons with diabetes developing diabetic retinopathy in India: A systematic review and meta-analysis
Q64285261Evaluating All Potential Oral Complications of Diabetes Mellitus
Q97530407Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series
Q33607767Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion
Q64248194Evaluation of multiple risk factors involved in the development of Diabetic Retinopathy
Q88692179Evaluation of optic disc, retinal nerve fiber and macular ganglion cell layers in pediatric diabetes
Q53013320Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy.
Q35171497Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
Q48021114Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes
Q34889065Evidence underlying the clinical management of diabetic macular oedema.
Q28075473Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines
Q90197764Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life
Q92410327Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
Q99635845Eye care utilization among diabetics in the South African National Health and Nutrition Examination Survey (SANHANES-1): a cross-sectional study
Q28546854FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy
Q91788680Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
Q91875398Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4)
Q92265948Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases
Q100559375Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy
Q33684390Familial History of Diabetes is Associated with Poor Glycaemic Control in Type 2 Diabetics: A Cross-sectional Study
Q97645328Feasibility of a cluster randomized controlled trial on the effectiveness of peer-led health education interventions to increase uptake of retinal examination for diabetic retinopathy in Kirinyaga, Kenya: a pilot trial
Q95275220Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial
Q47132940Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data.
Q94596430Females with Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve-Province Cross-Sectional Study in China
Q30248492Fenofibrate and Diabetic Retinopathy
Q94340447Fenofibrate for diabetic retinopathy
Q50446490Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
Q28068032Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
Q26852189Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema
Q34555355Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema
Q34758061Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
Q41096571Follow-up of the retinal nerve fiber layer thickness of diabetic patients type 2, as a predisposing factor for glaucoma compared to normal subjects
Q33914662Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study
Q35140341Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema
Q51202732Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy.
Q35935835Future opportunities in diabetic retinopathy research
Q97567741Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Q47757436Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study
Q94600785Genetics of diabetes mellitus and diabetes complications
Q35739097Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy
Q55332045Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy.
Q72435485Genome-wide association study for proliferative diabetic retinopathy in Africans
Q92602572Global Assessment of Retinal Arteriolar, Venular and Capillary Microcirculations Using Fundus Photographs and Optical Coherence Tomography Angiography in Diabetic Retinopathy
Q46638002Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Q64070450Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis
Q96225063Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling
Q38730387Glycated hemoglobin A1C and vitamin D and their association with diabetic retinopathy severity
Q100515982Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis
Q54990705Gonadal Hormones and Retinal Disorders: A Review.
Q58087851Granular lesions of short-wavelength and near-infrared autofluorescence in diabetic macular oedema
Q92642623Guidelines for the prevention and management of diabetic retinopathy and diabetic eye disease in India: A synopsis
Q40364101HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics
Q39364380Health-related quality of life of Finnish patients with diabetes
Q37718835Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
Q64069710Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review
Q50085138Hematopoietic stem/progenitor involvement in retinal microvascular repair during diabetes: Implications for bone marrow rejuvenation.
Q35681309High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes.
Q35870130High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico
Q92131187How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments?
Q94461782Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment
Q38658492Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.
Q90065220Hypertension, blood pressure control and diabetic retinopathy in a large population-based study
Q39042956Hypertensive eye disease: a review.
Q38614087Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy
Q47104735IGF1 gene polymorphisms associated with diabetic retinopathy risk in Chinese Han population
Q86561866Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis
Q92771204Identification of novel differentially expressed genes in retinas of STZ-induced long-term diabetic rats through RNA sequencing
Q31134280Identification of novel drug targets for the treatment of diabetic retinopathy
Q64059815Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program
Q35234189Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.
Q35892696Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy
Q55201911Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies.
Q99239952Impact of Socioeconomic Disadvantage and Diabetic Retinopathy Severity on Poor Ophthalmic Follow-Up in a Rural Vermont and New York Population
Q36100154Impact of educational interventions in reducing diabetic complications: a systematic review
Q53282743Impact of estimated glomerular filtration rate on diabetic macular edema.
Q36955704Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
Q35007582Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes.
Q39218792Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study
Q33871462Improving Consensus Scoring of Crowdsourced Data Using the Rasch Model: Development and Refinement of a Diagnostic Instrument
Q92298815Improving diabetic and hypertensive retinopathy with a medical food containing L-methylfolate: a preliminary report
Q31050639Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment
Q36091590In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography
Q57951352Incidence and progression of diabetic retinopathy within a private diabetes mellitus clinic in South Africa
Q90058779Incidence and progression of diabetic retinopathy: a systematic review
Q57922412Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study
Q96680410Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents
Q41122443Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy.
Q30363053Increased Retinal Oxygen Metabolism Precedes Microvascular Alterations in Type 1 Diabetic Mice.
Q37161442Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy
Q49935713Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.
Q99583151Increased vitreal levels of interleukin-10 in diabetic retinopathy: a Meta-analysis
Q93066925Indications and outcomes of vitrectomy surgery in a series of 1000 black African eyes
Q38608819Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.
Q46081457Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials
Q47360842Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes
Q48308519Influence of glycosylated hemoglobin on the choroidal thickness.
Q64112936Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic Retinopathy
Q46165292Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy
Q60912827Inhibition of stromal cell-derived factor-1α/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas
Q96685477Insights into the growing popularity of artificial intelligence in ophthalmology
Q30718043Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy
Q101237502Intensive treat-to-target statin therapy and severity of diabetic retinopathy complicated by hypercholesterolaemia
Q90731596Internal fat mediates the impact of age on diabetes onset in chinese people between 30 and 44 years old
Q24186687Interventions to increase attendance for diabetic retinopathy screening
Q47559649Interventions to increase attendance for diabetic retinopathy screening.
Q30681823Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy
Q53511112Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
Q92465248Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
Q49241521Intravitreal dexamethasone implants for diabetic macular edema.
Q90578278Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
Q33814542Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.
Q37734051Inverse Association between Serum Bilirubin Levels and Retinopathy in Patients with Type 2 Diabetes Mellitus
Q34655098Inverse association between high blood 25-hydroxyvitamin D levels and diabetic retinopathy in a representative Korean population
Q35685140Investigating Factors Associated with Depression of Type 2 Diabetic Retinopathy Patients in China
Q58762930Investigating the Fractal Dimension of the Foveal Microvasculature in Relation to the Morphology of the Foveal Avascular Zone and to the Macular Circulation in Patients With Type 2 Diabetes Mellitus
Q34514392Investigation of variants in UCP2 in Chinese type 2 diabetes and diabetic retinopathy
Q88796123Involvement of ciliary neurotrophic factor in early diabetic retinal neuropathy in streptozotocin-induced diabetic rats
Q33614579Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study
Q30372692Is fenofibrate a reasonable treatment for diabetic microvascular disease?
Q57145910Is there a relationship between body mass index and diabetic retinopathy in type II diabetic patients? A cross sectional study
Q40050054Is there any correlation between vitamin D insufficiency and diabetic retinopathy?
Q39699517Kernel regression based segmentation of optical coherence tomography images with diabetic macular edema.
Q38171217Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways.
Q89457085Knowledge and practices of fundoscopy among general practitioners in Qassim Province, Saudi Arabia, for the management of diabetic retinopathy and diabetic macular edema: A cross-sectional study
Q92073661Knowledge and practices of primary care physicians on the current referral system of diabetic retinopathy in Islamabad and Rawal-Pindi, Pakistan
Q94601616Large-Scale Neuronal Network Dysfunction in Diabetic Retinopathy
Q26995365Laser, intravitreal drug application, and surgery to treat diabetic eye disease
Q92150307Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study
Q42378533LncRNAs: key players and novel insights into diabetes mellitus
Q98178541Long-Term Tea Consumption Is Associated with Reduced Risk of Diabetic Retinopathy: A Cross-Sectional Survey among Elderly Chinese from Rural Communities
Q26799531Long-term Outcomes in Youths with Diabetes Mellitus
Q28292764Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
Q57920483Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study
Q64907084Lycium Barbarum Polysaccharides Improve Retinopathy in Diabetic Sprague-Dawley Rats.
Q52309509MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy.
Q36613656Machine Learning Approaches for Detecting Diabetic Retinopathy from Clinical and Public Health Records
Q38791673Machine Learning Methods to Predict Diabetes Complications.
Q47978837Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes.
Q89795782Macular Optical Coherence Tomography Angiography in Nephropathic Patients with Diabetic Retinopathy in Iran: A Prospective Case-Control Study
Q35728048Macular ischemia and outcome of vitrectomy for diabetic macular edema
Q87273692Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy
Q92621245Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
Q35931863Magnitude and determinants of diabetic retinopathy among persons with diabetes registered at employee health department of a tertiary Eye Hospital of central Saudi Arabia
Q38302499Male-female differences in diabetic retinopathy?
Q48579709Management of diabetic macular edema in Japan: a review and expert opinion.
Q38882106Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?
Q40144050Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment
Q60919942Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes
Q33719419Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus
Q55399207Metamorphopsia Score and Central Visual Field Outcomes in Diabetic Cystoid Macular Edema.
Q28088750Methods and algorithms for optical coherence tomography-based angiography: a review and comparison
Q91762118MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Q33603455Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
Q42362614Milestones in blindness prevention in India
Q35666228Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).
Q33631921Minireview: Challenges and opportunities in development of PPAR agonists
Q47113167Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes
Q53270174Modeling long-term diabetes and related complications in rats.
Q57183608Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
Q27014620Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets
Q28078199Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Q62477925Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control
Q44618729Multifocal electroretinogram responses in Nepalese diabetic patients without retinopathy.
Q35544948Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure
Q47954026Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.
Q47911906NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression
Q47094741NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.
Q43191572NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.
Q89529534NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
Q30579323NRF2 plays a protective role in diabetic retinopathy in mice
Q36396201Nanoparticle-motivated gene delivery for ophthalmic application
Q35188001NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice
Q38693846Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro
Q36063335National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy
Q90060268Network Pharmacology-based Investigation of the Underlying Mechanism of Panax Notoginseng Treatment of Diabetic Retinopathy
Q90376643Neurodegeneration in diabetic retinopathy: does it really matter?
Q26798351Neuroinflammatory responses in diabetic retinopathy
Q92105332New Lipid Mediators in Retinal Angiogenesis and Retinopathy
Q33583037New Therapeutic Approaches in Diabetic Retinopathy
Q38710250New insights: A role for O-GlcNAcylation in diabetic complications
Q55155684Non-Mydriatic Fundus Retinography in Screening for Diabetic Retinopathy: Agreement Between Family Physicians, General Ophthalmologists, and a Retinal Specialist.
Q90455503Non-mydriatic fundus camera screening with diagnosis by telemedicine for diabetic retinopathy patients with type 1 and type 2 diabetes: a hospital-based cross-sectional study
Q37204025Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review
Q41717724Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Q99585116Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
Q28066675Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
Q49380314Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
Q50874501Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.
Q38094006Nuclear GAPDH: changing the fate of Müller cells in diabetes
Q35970441O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells
Q55208760Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
Q35549983Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy
Q50582610Optic disc detection in retinal fundus images using gravitational law-based edge detection.
Q38987112Optical Coherence Tomography Angiography in Diabetes
Q24186424Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
Q96954253Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review
Q34693503Optimal treatment of diabetic retinopathy
Q92152517Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
Q64882207Out of darkness comes light-is there a role for light masks in treatment of diabetic macular oedema?
Q47095285Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema
Q38480783Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy.
Q46248374Oxidative stress and reactive oxygen species: a review of their role in ocular disease
Q38019841Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies
Q35589517P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans
Q96950447PPARα activation directly upregulates thrombomodulin in the diabetic retina
Q64245243Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes
Q48227262Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Q60301928Pathological changes in the cellular structures of retina and choroidea in the early stages of alloxan-induced diabetes
Q58591190Pathophysiology of Diabetic Retinopathy: The Old and the New
Q47761979Patient Attitudes Toward Telemedicine for Diabetic Retinopathy.
Q35230987Patient characteristics associated with measurement of routine diabetes care: an observational study
Q92407666Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR
Q37723748Pattern Visual Evoked Potential Changes in Diabetic Patients without Retinopathy.
Q91598448Pattern and Presentation of Vitreo-Retinal Diseases: An Analysis of Retrospective Data at a Tertiary Eye Care Center in Nepal
Q58778173Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
Q89167709Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging
Q92187715Pericytes: Problems and Promises for CNS Repair
Q39055178Periodontitis is associated with diabetic retinopathy in non-obese adults
Q91062954Peripapillary microvasculature in patients with diabetes mellitus: An optical coherence tomography angiography study
Q36318318Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema
Q57035913Personalized risk-based screening for diabetic retinopathy: a multivariate approach vs. the use of stratification rules
Q26786012Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Q64058295Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy
Q49384584Pharmacologic management of diabetic retinopathy.
Q93006844Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice
Q36610531Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients.
Q36608921Pilot study using mobile health to coordinate the diabetic patient, diabetologist, and ophthalmologist
Q111822859Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
Q37093044Planning a programme to prevent visual loss from diabetic retinopathy
Q36104687Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema
Q51269699Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema.
Q26859982Plasma kallikrein-kinin system and diabetic retinopathy
Q51069605Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Q55364528Possible neuroprotective role of P2X2 in the retina of diabetic rats.
Q48213393Potential beneficial effect of low-dose danazol in combination with renin-angiotensin system inhibitors in diabetic macular oedema.
Q39126178Potential regulatory mechanisms of lncRNA in diabetes and its complications
Q90695615Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery
Q58129903Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms
Q92399114Prediction of Proliferative Diabetic Retinopathy to Asymptomatic Obstructive Coronary Artery Disease in Chinese Type 2 Diabetes Individuals: An Exploratory Study
Q93150629Predictive Models for Diabetic Retinopathy from Non-Image Teleretinal Screening Data
Q33606076Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.
Q64268367Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Q52938566Predictors of Photographic Quality with a Handheld Nonmydriatic Fundus Camera Used for Screening of Vision-Threatening Diabetic Retinopathy.
Q47149927Predictors of uptake of eye examination in people living with diabetes mellitus in three counties of Kenya
Q92998065Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
Q93102470Presbyopia and Other Eye Conditions in Teachers in Ghana
Q30244246Presence and Risk Factors for Glaucoma in Patients with Diabetes
Q35663730Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study
Q47167329Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study
Q43087824Prevalence and associated factors of diabetic retinopathy in rural central India
Q90579091Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes
Q92767550Prevalence and causes of avoidable blindness and visual impairment, including the prevalence of diabetic retinopathy in Siwan district of Bihar, India: A population-based survey
Q35502290Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia
Q41328655Prevalence and causes of low vision and blindness in a Chinese population with type 2 diabetes: the Dongguan Eye Study.
Q38199083Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010.
Q91917437Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study
Q36295183Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study
Q34992483Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey
Q38818921Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark
Q90148019Prevalence and risk factors for diabetic retinopathy in a cross-sectional population-based study from rural southern China: Dongguan Eye Study
Q55006702Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: the Bhaktapur Retina Study.
Q42052435Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies
Q93118971Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study
Q38387608Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure
Q47155478Prevalence of Diabetic Retinopathy and its Associated Factors in a Rural Area of Villupuram District of Tamil Nadu, India
Q40460731Prevalence of Diabetic Retinopathy in Urban Slums: The Aditya Jyot Diabetic Retinopathy in Urban Mumbai Slums Study-Report 2.
Q34433671Prevalence of and risk factors for diabetic macular edema in the United States
Q55445642Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.
Q42656602Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study.
Q53080674Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study.
Q33706116Prevalence of diabetic retinopathy in Iran: a systematic review and Meta-analysis
Q55063040Prevalence of diabetic retinopathy in Pakistan; A systematic review.
Q38075074Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries
Q36374753Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain)
Q39675641Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS).
Q39148804Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
Q64244861Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis
Q37595628Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa
Q38995550Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors.
Q34076715Prevalence of retinopathy among adults with self-reported diabetes mellitus: the Sri Lanka diabetes and Cardiovascular Study
Q46965530Prevalence, Awareness and Determinants of Diabetic Retinopathy in a Screening Centre in Nigeria
Q55262838Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: A cross-sectional study.
Q37166969Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study
Q30991231Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance
Q90084589Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis
Q55099824Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis.
Q92463074Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema
Q28661253Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study
Q33828636Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
Q61810069Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney)
Q104485901Progress in examining cost-effectiveness of AI in diabetic retinopathy screening
Q100430570Progress of artificial intelligence in diabetic retinopathy screening
Q36369491Proliferative diabetic retinopathy: laser or eye injection?
Q93181086Protection by vitamin D against high-glucose-induced damage in retinal pigment epithelial cells
Q38654549Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction
Q64907800Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy.
Q36502289Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression
Q64246319Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation
Q90249496Protective roles of autophagy in retinal pigment epithelium under high glucose condition via regulating PINK1/Parkin pathway and BNIP3L
Q89002577Psychophysical Exams as Early Indicators of Diabetic Retinopathy
Q93223915Public health system integration of avoidable blindness screening and management, India
Q58040299Pursuing type 1 diabetes mellitus and related complications through urinary proteomics
Q39148545Putative protective role of lutein and zeaxanthin in diabetic retinopathy
Q41034223Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography
Q33741713Quality of Life in People with Diabetic Retinopathy: Indian Study
Q48272704Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study
Q64241331Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography
Q92727494Quantitative Microvascular Analysis With Wide-Field Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy
Q59797551RF/6A Chorioretinal Cells Do Not Display Key Endothelial Phenotypes
Q55316713Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema.
Q36235336Rationale and Methodology for a Community-Based Study of Diabetic Retinopathy in an Indonesian Population with Type 2 Diabetes Mellitus: The Jogjakarta Eye Diabetic Study in the Community
Q39307436Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease
Q92533148Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
Q37603037Real-Life ILUVIEN (Fluocinolone Acetonide) Case Study: Rapid Drying of the Macula and Improved Vision within 2 Years after Therapy Initiation
Q94464949Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes
Q58804239Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Q89172339Real-life experience of ranibizumab for diabetic macular edema in Taiwan
Q90751266Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
Q38671399Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
Q38665017Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.
Q90314995Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study
Q64911569Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.
Q38747087Recent Advancements in Retinal Vessel Segmentation.
Q39079275Recent advances in molecular biomarkers for diabetes mellitus: a systematic review
Q54956778Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.
Q47096339Recurrent Diabetic Macular Edema: What to Do.
Q53388406Reduced Amputation Rate by Circular TNP Application on Split-Skin Grafts After Deep Dermal Foot Scalds in Insulin-Dependent Diabetic Patients.
Q51701226Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Q52560208Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes.
Q37222342Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography.
Q55049881Regional differences in the prevalence of diabetic retinopathy: a multi center study in Brazil.
Q33563100Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema
Q26774344Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Q35866161Relationship between Diabetic Retinopathy and Subclinical Hypothyroidism: a meta-analysis
Q37045034Relationship between Functional and Structural Changes in Diabetic Vessels in Optical Coherence Tomography Angiography
Q98290104Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers
Q91559826Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea
Q92471958Relationship between diabetic macular edema and choroidal layer thickness
Q41571864Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland
Q33585807Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway
Q47928006Resting heart rate is associated with nonproliferative retinopathy in normoalbuminuric type 1 diabetic patients.
Q39102573Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema
Q41625930Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases
Q92422679Retinal Blood Velocity and Flow in Early Diabetes and Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy
Q38605095Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy
Q36070169Retinal Image Enhancement Using Robust Inverse Diffusion Equation and Self-Similarity Filtering
Q35910183Retinal Imaging Techniques for Diabetic Retinopathy Screening
Q99561828Retinal Physiology and Circulation: Effect of Diabetes
Q64937118Retinal Vasculature in Development and Diseases.
Q58730421Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril
Q90154071Retinal exams requested at Primary Care Unit: indications, results and alternative strategies of evaluation
Q48260488Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor Darapladib.
Q90269763Retinal vasculature-function correlation in non-proliferative diabetic retinopathy
Q91593821Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy
Q47099578Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors.
Q51015951Retinopathy with central oedema in an INS C94Y transgenic pig model of long-term diabetes.
Q48416276Retinopathy, nephropathy, peripheral neuropathy and geriatric scale scores in elderly people with Type 2 diabetes.
Q38673270Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015.
Q42367664Reversible retinal vessel closure from VEGF-induced leukocyte plugging
Q101476472Review of retinal cameras for global coverage of diabetic retinopathy screening
Q55518628Review on the prevalence of diabetes and risk factors and situation of disease management in floating population in China.
Q36853930Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes
Q35803183Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection
Q35692338Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database
Q92106288Risk Factors of Thyroid Dysfunction in Patients With Type 2 Diabetes Mellitus
Q58760646Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
Q54877898Risk factors for diabetic retinopathy: a case-control study.
Q37275536Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetes
Q37257978Risk factors of retinopathy in type 2 diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan
Q42364223Role of Angiopoietins and Tie-2 in Diabetic Retinopathy
Q92594491Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography
Q35104388Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population.
Q39238324Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy
Q26775853Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Q42330281Role of lipid-lowering agents in the management of diabetic retinopathy
Q27016431Role of plasma kallikrein in diabetes and metabolism
Q41891788Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.
Q37038437Scientometric Analysis and Mapping of Scientific Articles on Diabetic Retinopathy
Q40502875Screening Intervals for Diabetic Retinopathy and Implications for Care
Q34717944Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea
Q42372185Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device
Q89954644Screening for diabetic retinopathy: new perspectives and challenges
Q50081277Screening for vision-threatening diabetic retinopathy in South India: comparing portable non-mydriatic and standard fundus cameras and clinical exam.
Q38118778Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review
Q42292862Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
Q47386296Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway.
Q47879810Secretogranin III: a diabetic retinopathy-selective angiogenic factor.
Q58608160Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery
Q47409299Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Q41695768Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy
Q36241451Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
Q87145995Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage
Q36832811Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients
Q36992469Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes
Q88542920Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps
Q58782172Severity of diabetic retinopathy at the first ophthalmological examination in the Lebanese population
Q64092868Sex Differences in the Prevalence, Awareness, Treatment, and Control of Diabetes Mellitus Among Adults Aged 45 Years and Older in Rural Areas of Northern China: A Cross-Sectional, Population-Based Study
Q90427791Shared Care for Patients with Diabetes at Risk of Retinopathy: A Feasibility Trial
Q90078739Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane
Q90637855Single herbal medicine for diabetic retinopathy
Q36842799Situational analysis of services for diabetes and diabetic retinopathy and evaluation of programs for the detection and treatment of diabetic retinopathy in India: Methods for the India 11-city 9-state study
Q47831386Sleep and diabetic retinopathy.
Q35111271Social deprivation as a risk factor for late presentation of proliferative diabetic retinopathy
Q47115045Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal
Q38195792Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives
Q60947291Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
Q47117481Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
Q92642568Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India
Q92642566Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus
Q42701686Specvis: Free and open-source software for visual field examination.
Q41393449Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.
Q36638879Structural Changes by Spectral Domain Optical Coherence Tomography in Patients With Type 1 Diabetes Mellitus
Q36357725Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period
Q52979847Study methodology and diabetes control in patients from the non-English diabetes management project (NEDMP).
Q35553181Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema
Q48277485Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography
Q48099937Study of retinal neurodegeneration and maculopathy in diabetic Meriones shawi: A particular animal model with human-like macula.
Q49827430Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature.
Q91809852Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema
Q36848538Suitability of a Low-Cost, Handheld, Nonmydriatic Retinograph for Diabetic Retinopathy Diagnosis.
Q92447094Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease
Q47918653Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Q89531841Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Q63435749Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy
Q47108753Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
Q64067357Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
Q50021425Symmetry of peripheral retinal nonperfusion in diabetic retinopathy by ischemic index.
Q49244967Synergistic interaction between prolonged increased glycemic exposure and mildly increased urinary albumin excretion on diabetic retinopathy.
Q47701463Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery
Q58603294Systematic review and meta-analysis of diagnostic accuracy of detection of any level of diabetic retinopathy using digital retinal imaging
Q35231230Systematic review of various laser intervention strategies for proliferative diabetic retinopathy.
Q40305170Systematic screening for diabetic retinopathy (DR) in Hong Kong: prevalence of DR and visual impairment among diabetic population.
Q91842400Systemic Factors Associated with Treatment Response in Diabetic Macular Edema
Q98163435Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus
Q36123333Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease.
Q35067111Systemic medical management of diabetic retinopathy
Q36939054TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes
Q90027408TRPV4 Channels as Therapeutic Targets in Diabetes and Diabetes-related Complications
Q38990050Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Q34275560Telemedicine and ocular health in diabetes mellitus
Q27014047Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis
Q38898370Telemedicine in diabetic retinopathy: Access to rural India
Q35544166Telemedicine in diabetic retinopathy: current status and future directions
Q64977149Teleophthalmology Support for Primary Care Diagnosis and Management.
Q47203189Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study
Q38880569Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy
Q46407140Ten years of anti-vascular endothelial growth factor therapy
Q34408245Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011.
Q26748944The Adenosinergic System in Diabetic Retinopathy
Q34545993The Association between VDR Gene Polymorphisms and Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis
Q60907887The Association of CEP135 rs4865047 and NPY2R rs1902491 Single Nucleotide Polymorphisms (SNPs) with Rapid Progression of Proliferative Diabetic Retinopathy in Patients with Type 1 Diabetes Mellitus
Q36044969The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012.
Q64916531The Association of Serum Leptin Level and Anthropometric Measures With the Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus.
Q49181841The Beijing Desheng Diabetic Eye Study: rationale, design, methodology and baseline data.
Q92538952The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells
Q91966635The Detection and Partial Localisation of Heteroplasmic Mutations in the Mitochondrial Genome of Patients with Diabetic Retinopathy
Q28075888The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
Q35902518The Effects of Diabetic Retinopathy and Pan-Retinal Photocoagulation on Photoreceptor Cell Function as Assessed by Dark Adaptometry
Q41171782The Effects of the Contact Activation System on Hemorrhage
Q90409273The Evolving Treatment of Diabetic Retinopathy
Q102060110The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Q49169179The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
Q37418776The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application.
Q36245823The Prevention and Treatment of Retinal Complications in Diabetes
Q64285140The Role of Adiponectin and Toll-Like Receptor 4 Gene Polymorphisms on Non-Proliferative Retinopathy in Type 2 Diabetes Mellitus Patients. A Case control Study in Romanian Caucasians Patients
Q48211404The Role of Glycemic Control and Variability in Diabetic Retinopathy
Q37548105The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications.
Q39007482The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management
Q102220279The SUSTech-SYSU dataset for automated exudate detection and diabetic retinopathy grading
Q41229548The Status of Maculopathy in Diabetes and Prediabetes Patients in a Population-Based Study Detected by Optical Coherence Tomography: The 2011 Health Examination Survey in Beijing
Q51430597The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown.
Q64971142The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema.
Q26783404The Vitreomacular Interface in Diabetic Retinopathy
Q91598423The War on Diabetic Retinopathy: Where Are We Now?
Q35301427The association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010.
Q89616540The association between eating behavior and polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 genes in people with type 2 diabetes mellitus
Q40968743The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes
Q37212766The association of physical activity and cholesterol concentrations across different combinations of central adiposity and body mass index
Q38828410The changing face of diabetes complications
Q98727175The corneal effects of intravitreal dexamethasone implantation
Q34615668The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial
Q98237750The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis
Q38150855The evolving treatment options for diabetic macular edema
Q48290530The eye as a complement dysregulation hotspot.
Q38396875The genetics of diabetic complications
Q91892449The impact of artificial intelligence in screening for diabetic retinopathy in India
Q90197758The impact of artificial intelligence in the diagnosis and management of glaucoma
Q35048504The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia
Q35618267The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study.
Q38692341The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future.
Q92621182The profile of sight-threatening diabetic retinopathy in patients attending a specialist eye clinic in Hangzhou, China
Q95933519The purchase of the Diabetic Healthy Food Basket in Cyprus results in cost savings: is it affordable among the low-income population?
Q94585827The relationship between carotid disease and retinopathy in diabetes: a systematic review
Q47731172The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes.
Q33683197The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy
Q36744879The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
Q58784813The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
Q92025135The role of steroids in treating diabetic macular oedema in the era of anti-VEGF
Q36461851The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
Q90575860The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy
Q30394609The worldwide epidemic of diabetic retinopathy.
Q92120247Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study
Q38873909Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy
Q50049076Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.
Q53097624Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema.
Q36612276Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint
Q60300737Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
Q31005299Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications
Q91805508Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke
Q64106481Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Q104070104Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
Q30235021Type 1 diabetes mellitus
Q35711668Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping
Q89844956U.S. county "food swamp" severity and hospitalization rates among adults with diabetes: A nonlinear relationship
Q64107754Unfolded Protein Response Pathways Correlatively Modulate Endoplasmic Reticulum Stress Responses in Rat Retinal Müller Cells
Q37406852United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services.
Q38285522Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
Q39427264Update on Diagnosis and Treatment of Diabetic Retinopathy: A Consensus Guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society).
Q92319046Update on Screening for Sight-Threatening Diabetic Retinopathy
Q26773225Update on genetics and diabetic retinopathy
Q36298105Update on wide- and ultra-widefield retinal imaging
Q53421840Urban-rural differences in the prevalence of diabetes mellitus among 25-74 year-old adults of the Yangon Region, Myanmar: two cross-sectional studies.
Q38719213Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice
Q92860697Ursodeoxycholic Acid Attenuates the Retinal Vascular Abnormalities in Anti-PDGFR-β Antibody-Induced Pericyte Depletion Mouse Models
Q38949051Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind
Q35884438Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting
Q36885757Usefulness of Discarded Vitreous Samples from Routine Vitrectomy
Q35075399Using Markov Chains to predict the natural progression of diabetic retinopathy
Q47311711Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System
Q92125814Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat
Q55091488Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.
Q36266894Virtual screening of RAGE inhibitors using molecular docking
Q36537266Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy
Q38773655Vitamin D and diabetes mellitus: Causal or casual association?
Q52571010Vitamin D3 Protects against Diabetic Retinopathy by Inhibiting High-Glucose-Induced Activation of the ROS/TXNIP/NLRP3 Inflammasome Pathway.
Q92623020Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema
Q38293676Vitreous humor in the pathologic scope: insights from proteomic approaches.
Q55007680Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Q36182391White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging
Q35745813Wide-Field Megahertz OCT Imaging of Patients with Diabetic Retinopathy.
Q64084236Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Q36049918Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms
Q49808386[Expression of VEGF and PEDF in early-stage retinopathy in diabetic Macaca mulatta].
Q92168513[Prevalence and risk factors associated with diabetic retinopathy in Santander. Northern Spain]
Q90394480circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications
Q89017438iT2DMS: a Standard-Based Diabetic Disease Data Repository and its Pilot Experiment on Diabetic Retinopathy Phenotyping and Examination Results Integration
Q47116645miRNA-1273g-3p Involvement in Development of Diabetic Retinopathy by Modulating the Autophagy-Lysosome Pathway.
Q54978588miR‑133b regulates proliferation and apoptosis in high‑glucose‑induced human retinal endothelial cells by targeting ras homolog family member A.
Q48096036p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy.

Search more.